The Indian Medical Association on Thursday questioned the scientific basis of the government's recently released protocol based on ayurveda and yoga for the prevention as well as treatment of asymptomatic and mild patients of COVID-19.
Union Health Minister Harsh Vardhan on Tuesday released a protocol for the clinical management of COVID-19, that lists dietary measures, yoga and ayurvedic herbs and formulations such as Ashwagandha and AYUSH-64 for prevention of coronavirus infection and treatment of mild and asymptomatic cases.
"Whether the proponents of this claim and his Ministry are prepared to subject themselves as volunteers to an independent prospective double-blind control study in prevention and treatment of COVID? How many of his ministerial colleagues have so far made the informed choice of getting treated under these protocols?" the IMA asked.
"What is stopping him from handing over COVID care and control to AYUSH ministry? IMA demands that the Union Health Minister should come clean on the above posers. If not, he is inflicting a fraud on the nation and gullible patients by calling placebos as drugs," it added.
Questioning the scientific basis of these protocols, the IMA has asked the health minister "to give reproducibility of a claim elsewhere in non-conflict situations and double blind control studies".
A double blind study is a randomized clinical trial in which the person does not know if they are receiving the experimental treatment, a standard treatment or a placebo. Placebo is a substance or treatment which is designed to have no therapeutic value.
"Is there satisfactory evidence regarding the claims made from studies done on COVID-19 patients based on the above criteria? If so, whether the evidence is weak or moderate or strong? The evidence should be in public domain and available for scientific scrutiny," it said in a statement.
The IMA asked "whether the severe form of COVID-19 a hyperimmune status or an immune deficiency status?"
The IMA demanded that the Union Health Minister respond to these posers. "If not, he is inflicting a fraud on the nation and gullible patients by calling placebos as drugs," it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)